{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:23:16Z","timestamp":1791109396665,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":2502,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1038\/mt.2009.174","type":"journal-article","created":{"date-parts":[[2009,8,13]],"date-time":"2009-08-13T02:47:36Z","timestamp":1250131656000},"page":"2031-2040","source":"Crossref","is-referenced-by-count":41,"title":["Generating Differentially Targeted Amyloid-\u03b2 Specific Intrabodies as a Passive Vaccination Strategy for Alzheimer's Disease"],"prefix":"10.1016","volume":"17","author":[{"given":"Kelly L","family":"Sudol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Mastrangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wade C","family":"Narrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E","family":"Frazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yona R","family":"Levites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd E","family":"Golde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard J","family":"Federoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J","family":"Bowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2009.174_bib1","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/j.1460-2075.1985.tb04000.x","article-title":"Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels","volume":"4","author":"Masters","year":"1985","journal-title":"EMBO J"},{"key":"10.1038\/mt.2009.174_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3233\/JAD-2001-3208","article-title":"Apoptotic neurons in Alzheimer's disease frequently show intracellular Abeta42 labeling","volume":"3","author":"Chui","year":"2001","journal-title":"J Alzheimers Dis"},{"key":"10.1038\/mt.2009.174_bib3","doi-asserted-by":"crossref","first-page":"15666","DOI":"10.1074\/jbc.M200887200","article-title":"Intracellular amyloid-beta 1-42, but not extracellular soluble amyloid-beta peptides, induces neuronal apoptosis","volume":"277","author":"Kienlen-Campard","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2009.174_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng0195-21","article-title":"The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice","volume":"9","author":"LaFerla","year":"1995","journal-title":"Nat Genet"},{"key":"10.1038\/mt.2009.174_bib5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.0953-816X.2003.03135.x","article-title":"Enhanced generation of intracellular Abeta42 amyloid peptide by mutation of presenilins PS1 and PS2","volume":"19","author":"Takeda","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1038\/mt.2009.174_bib6","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1021\/bi000169p","article-title":"Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells","volume":"39","author":"Misonou","year":"2000","journal-title":"Biochemistry"},{"key":"10.1038\/mt.2009.174_bib7","doi-asserted-by":"crossref","first-page":"11923","DOI":"10.1523\/JNEUROSCI.2795-06.2006","article-title":"Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice","volume":"26","author":"Levites","year":"2006","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2009.174_bib8","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nbt1142","article-title":"Engineered antibody fragments and the rise of single domains","volume":"23","author":"Holliger","year":"2005","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2009.174_bib9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0022-1759(99)00158-1","article-title":"Extended half-life and elevated steady-state level of a single-chain Fv intrabody are critical for specific intracellular retargeting of its antigen, caspase-7","volume":"231","author":"Zhu","year":"1999","journal-title":"J Immunol Methods"},{"key":"10.1038\/mt.2009.174_bib10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S1471-4914(03)00163-1","article-title":"Intracellular antibodies and challenges facing their use as therapeutic agents","volume":"9","author":"Lobato","year":"2003","journal-title":"Trends Mol Med"},{"key":"10.1038\/mt.2009.174_bib11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0167-7799(00)88970-2","article-title":"Intracellular antibodies: development and therapeutic potential","volume":"13","author":"Richardson","year":"1995","journal-title":"Trends Biotechnol"},{"key":"10.1038\/mt.2009.174_bib12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ymthe.2005.04.003","article-title":"Intrabody applications in neurological disorders: progress and future prospects","volume":"12","author":"Miller","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.174_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0169-328X(92)90191-D","article-title":"Expression of a carboxy-terminal region of the beta-amyloid precursor protein in a heterogeneous culture of neuroblastoma cells: evidence for altered processing and selective neurotoxicity","volume":"16","author":"Fukuchi","year":"1992","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1038\/mt.2009.174_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0378-1119(99)00045-1","article-title":"Efficient control of tetracycline-responsive gene expression from an autoregulated bi-directional expression vector","volume":"229","author":"Strathdee","year":"1999","journal-title":"Gene"},{"key":"10.1038\/mt.2009.174_bib15","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/nm0997-1021","article-title":"Alzheimer's A beta(1-42) is generated in the endoplasmic reticulum\/intermediate compartment of NT2N cells","volume":"3","author":"Cook","year":"1997","journal-title":"Nat Med"},{"key":"10.1038\/mt.2009.174_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.abb.2006.05.002","article-title":"Intracellular pathways of folded and misfolded amyloid precursor protein degradation","volume":"451","author":"Hare","year":"2006","journal-title":"Arch Biochem Biophys"},{"key":"10.1038\/mt.2009.174_bib17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.275.5300.630","article-title":"Alzheimer's disease: genotypes, phenotypes, and treatments","volume":"275","author":"Selkoe","year":"1997","journal-title":"Science"},{"key":"10.1038\/mt.2009.174_bib18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0962-8924(98)01363-4","article-title":"The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease","volume":"8","author":"Selkoe","year":"1998","journal-title":"Trends Cell Biol"},{"key":"10.1038\/mt.2009.174_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/nbdi.1997.0147","article-title":"Biology of A beta amyloid in Alzheimer's disease","volume":"4","author":"Wisniewski","year":"1997","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2009.174_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0928-4257(98)80035-1","article-title":"The role of A beta 42 in Alzheimer's disease","volume":"92","author":"Younkin","year":"1998","journal-title":"J Physiol Paris"},{"key":"10.1038\/mt.2009.174_bib21","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","article-title":"Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease","volume":"24","author":"Oddo","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1038\/mt.2009.174_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1038\/mt.2009.174_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2202-9-81","article-title":"Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic mice","volume":"9","author":"Mastrangelo","year":"2008","journal-title":"BMC Neurosci"},{"key":"10.1038\/mt.2009.174_bib24","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","article-title":"Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice","volume":"45","author":"Billings","year":"2005","journal-title":"Neuron"},{"key":"10.1038\/mt.2009.174_bib25","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1111\/j.1471-4159.2008.05517.x","article-title":"Functional interactions of APP with the apoE receptor family","volume":"106","author":"Hoe","year":"2008","journal-title":"J Neurochem"},{"key":"10.1038\/mt.2009.174_bib26","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/mt.2008.39","article-title":"Reduced pathology and improved behavioral performance in Alzheimer's disease mice vaccinated with HSV amplicons expressing amyloid-beta and interleukin-4","volume":"16","author":"Frazer","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.174_bib27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.neuron.2004.07.003","article-title":"Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome","volume":"43","author":"Oddo","year":"2004","journal-title":"Neuron"},{"key":"10.1038\/mt.2009.174_bib28","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1074\/jbc.M507892200","article-title":"Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology","volume":"281","author":"Oddo","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2009.174_bib29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2006.03.145","article-title":"Amelioration of amyloid load by anti-Abeta single-chain antibody in Alzheimer mouse model","volume":"344","author":"Fukuchi","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mt.2009.174_bib30","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.nbd.2006.04.012","article-title":"Anti-Abeta single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's disease","volume":"23","author":"Fukuchi","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2009.174_bib31","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1073\/pnas.071058398","article-title":"Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease","volume":"98","author":"Lecerf","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2009.174_bib32","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1083\/jcb.200410047","article-title":"beta-site specific intrabodies to decrease and prevent generation of Alzheimer's Abeta peptide","volume":"168","author":"Paganetti","year":"2005","journal-title":"J Cell Biol"},{"key":"10.1038\/mt.2009.174_bib33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jmb.2007.11.096","article-title":"An scFv intrabody against the nonamyloid component of alpha-synuclein reduces intracellular aggregation and toxicity","volume":"377","author":"Lynch","year":"2008","journal-title":"J Mol Biol"},{"key":"10.1038\/mt.2009.174_bib34","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1083\/jcb.141.4.1031","article-title":"Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture","volume":"141","author":"Skovronsky","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1038\/mt.2009.174_bib35","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1046\/j.1432-1033.2003.03722.x","article-title":"Evidence for proteasome dysfunction in cytotoxicity mediated by anti-Ras intracellular antibodies","volume":"270","author":"Cardinale","year":"2003","journal-title":"Eur J Biochem"},{"key":"10.1038\/mt.2009.174_bib36","doi-asserted-by":"crossref","first-page":"30874","DOI":"10.1074\/jbc.274.43.30874","article-title":"The PEST domain of IkappaBalpha is necessary and sufficient for in vitro degradation by mu-calpain","volume":"274","author":"Shumway","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2009.174_bib37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1525-0016(03)00043-1","article-title":"Regulated expression of erythropoietin from an AAV vector safely improves the anemia of beta-thalassemia in a mouse model","volume":"7","author":"Johnston","year":"2003","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.174_bib38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1046-2023(02)00226-8","article-title":"Regulation of gene expression in adeno-associated virus vectors in the brain","volume":"28","author":"Haberman","year":"2002","journal-title":"Methods"},{"key":"10.1038\/mt.2009.174_bib39","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1073\/pnas.91.6.2076","article-title":"Convection-enhanced delivery of macromolecules in the brain","volume":"91","author":"Bobo","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2009.174_bib40","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3171\/jns.2004.100.3.0472","article-title":"Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I\/II clinical study","volume":"100","author":"Lidar","year":"2004","journal-title":"J Neurosurg"},{"key":"10.1038\/mt.2009.174_bib41","first-page":"105","article-title":"Convection enhanced delivery of IL13-PE38QQR for treatment of recurrent malignant glioma: presentation of interim findings from ongoing phase 1 studies","volume":"88","author":"Kunwar","year":"2003","journal-title":"Acta Neurochir Suppl"},{"key":"10.1038\/mt.2009.174_bib42","article-title":"Real-time MR imaging of adeno-associated viral vector delivery to the primate brain","author":"Fiandaca","year":"2008","journal-title":"Neuroimage"},{"key":"10.1038\/mt.2009.174_bib43","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.2353\/ajpath.2008.080528","article-title":"Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice","volume":"173","author":"Janelsins","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1038\/mt.2009.174_bib44","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1089\/10430340260355347","article-title":"Insect cells as a factory to produce adeno-associated virus type 2 vectors","volume":"13","author":"Urabe","year":"2002","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2009.174_bib45","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.mt.6300387","article-title":"CNS delivery of vectored prion-specific single-chain antibodies delays disease onset","volume":"16","author":"Wuertzer","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.174_bib46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-2094-2-23","article-title":"Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice","volume":"2","author":"Janelsins","year":"2005","journal-title":"J Neuroinflammation"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616308188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616308188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T20:06:52Z","timestamp":1558469212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616308188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1525001616308188"],"URL":"https:\/\/doi.org\/10.1038\/mt.2009.174","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}